NCT05556772Active, not recruiting
Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic
Estudio Oportunidad: Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
This study compares different screening approaches to detect abnormal cell growth on the cervix that could be an early sign of cervical cancer. The lesions are caused by an infection of human papillomavirus, also called HPV. Using new methods to detect HPV may help doctors find ways to improve cervical cancer screening for women living with human immunodeficiency virus (HIV) in the Dominican Republic and in other countries.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 619 (actual)
- First submitted
- 29 Aug 2022
- Start date
- 14 Nov 2022
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Fred Hutchinson Cancer Center
- Diseases
- HIV, Cervical cancer
- NCT number
- NCT05556772
What you commit to
- Study type: Interventional
- Participants enrolled: 619
- From 14 Nov 2022 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Women with a prior diagnosis of cervical cancer or a history of treatment for cervical precancerous lesions (CIN2+) will be excluded
Other illness
- Women with significant physical, mental, or social conditions that would limit participation with study procedures will not be eligible for the study
- Women who have no history of vaginal sexual exposure will not be eligible for the study
Other
- Women who are pregnant or report an intent to become pregnant in the subsequent 3 months will not be eligible for the study
Who the study is looking for
- Women ages 25 - 49 years old will be eligible to participate in the study
- Women living with HIV who have an intact cervix
- Intent to reside in the Santo Domingo area
- Ability to attend routine study visits at IDCP for at least 24 months during the study. If women report that they anticipate relocating in the subsequent 24 months or anticipate difficulty attending study visits they will not be eligible
- Ability to understand the study timeline and procedures and the willingness to complete the informed consent process are also inclusion criteria
Age in the registry: 25 years to 49 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Dermatológico Dominicano y Cirugía de Piel (IDCP) "Dr. Huberto Bogaert Diaz" Coordinator of this site? Confirm its status | Santo Domingo | Dominican Republic | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.